Christoffel Boshoff - 23 Feb 2024 Form 4 Insider Report for PFIZER INC (PFE)

Role: Executive Vice President
Signature: Susan E. Grant, by power of atty., for Christoffel Boshoff
Issuer symbol: PFE
Transactions as of: 23 Feb 2024
Net transactions value: -$160,892
Form type: 4
Filing time: 27 Feb 2024, 13:44:05 UTC
Previous filing: 29 Dec 2023
Next filing: 28 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PFE	Common Stock	Options Exercise	$266,620	+9,752	+7%	$27.34	148,703	23 Feb 2024	Direct	F1
transaction	PFE	Common Stock	Tax liability	$12,714	-458	-0.31%	$27.76	148,245	23 Feb 2024	Direct	F2
transaction	PFE	Common Stock	Tax liability	$18,738	-675	-0.46%	$27.76	147,570	23 Feb 2024	Direct	F3
transaction	PFE	Common Stock	Tax liability	$215,703	-7,881	-5.3%	$27.37	139,689	23 Feb 2024	Direct	F4, F5
transaction	PFE	Common Stock	Tax liability	$8,328	-300	-0.21%	$27.76	139,389	24 Feb 2024	Direct	F2, F6
transaction	PFE	Common Stock	Award	$0	+15,455	+11%	$0.000000	154,844	25 Feb 2024	Direct	F7
transaction	PFE	Common Stock	Tax liability	$38,947	-1,403	-0.91%	$27.76	153,441	25 Feb 2024	Direct	F2, F6
transaction	PFE	Common Stock	Tax liability	$133,081	-4,794	-3.1%	$27.76	148,647	25 Feb 2024	Direct	F6, F8
holding	PFE	Common Stock						624	23 Feb 2024	By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Stock Appreciation Rights	Options Exercise	$0	-9,752	-100%	$0.000000^*	0	23 Feb 2024	Common Stock	9,752	$27.34	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2	The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
F3	The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F4	The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F5	Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F6	Price is the closing price of Pfizer common stock on February 23, 2024.
F7	The reported transaction constitutes the earn-out of performance share awards (including dividend equivalents thereon).
F8	The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of performance share awards (including dividend equivalents thereon).